Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference
March 01 2021 - 5:55AM
Business Wire
Asensus Surgical, Inc. (NYSE American: TRXC) (formerly
TransEnterix, Inc.), a medical device company that is digitizing
the interface between the surgeon and patient to pioneer a new era
of Performance-Guided Surgery, announced today that Anthony
Fernando, President and Chief Executive Officer, and Shameze
Rampertab, Executive Vice President and Chief Financial Officer,
will participate in the H.C. Wainwright Virtual Global Life
Sciences Conference taking place March 9 and March 10, 2021.
The Company’s presentation will be available for on-demand
beginning Tuesday, March 9, 2021 at 7:00 am ET.
The on-demand conference presentation will be available online
on the investor relations page of the Company’s website at
https://ir.asensus.com/events-and-presentations. Replays of the
webcasts will be archived on the website for approximately 90
days.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking the Clinical Intelligence to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the
Senhance® Surgical System powered by the Intelligent Surgical Unit™
(ISU™) to increase surgeon control and reduce surgical variability.
With the addition of machine vision, augmented intelligence, and
deep learning capabilities throughout the surgical experience, we
intend to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210301005217/en/
INVESTOR CONTACT: Mark Klausner or Mike Vallie,
443-213-0499 invest@asensus.com or MEDIA CONTACT: Kristin
Schaeffer CG Life kschaeffer@cglife.com
TransEnterix (AMEX:TRXC)
Historical Stock Chart
From Nov 2024 to Dec 2024
TransEnterix (AMEX:TRXC)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about TransEnterix Inc New (American Stock Exchange): 0 recent articles
More Transenterix, Inc. News Articles